Literature DB >> 21762814

AID targeting in antibody diversity.

Rushad Pavri1, Michel C Nussenzweig.   

Abstract

Antibody maturation requires class switch recombination (CSR) and somatic hypermutation (SHM), both of which are initiated by activation-induced cytidine deaminase (AID). AID deaminates cytosine residues resulting in mismatches that are differentially processed to produce double-strand breaks in Ig switch (S) regions that lead to CSR, or to point mutations in variable (V) exons resulting in SHM. Although AID was first thought to be Ig-specific, recent work indicates that it also targets a diverse group of non-Ig loci, including genes such as Bcl6 and c-myc, whose modification by AID results in lymphoma-associated mutations and translocations. Here, we review the recent literature on AID targeting and the role for transcriptional stalling in recruitment of this enzyme to Ig and non-Ig loci. We propose a model for AID recruitment based on transcriptional stalling, which reconciles several of the key features of SHM, CSR, and lymphoma-associated translocation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762814     DOI: 10.1016/B978-0-12-387663-8.00005-3

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  74 in total

1.  Hypervariable loci in the human gut virome.

Authors:  Samuel Minot; Stephanie Grunberg; Gary D Wu; James D Lewis; Frederic D Bushman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

Review 2.  The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential.

Authors:  Christopher S Nabel; Sara A Manning; Rahul M Kohli
Journal:  ACS Chem Biol       Date:  2011-10-31       Impact factor: 5.100

3.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

4.  53BP1 alters the landscape of DNA rearrangements and suppresses AID-induced B cell lymphoma.

Authors:  Mila Jankovic; Niklas Feldhahn; Thiago Y Oliveira; Israel T Silva; Kyong-Rim Kieffer-Kwon; Arito Yamane; Wolfgang Resch; Isaac Klein; Davide F Robbiani; Rafael Casellas; Michel C Nussenzweig
Journal:  Mol Cell       Date:  2013-01-03       Impact factor: 17.970

5.  Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase.

Authors:  Muneer G Hasham; Kathy J Snow; Nina M Donghia; Jane A Branca; Mark D Lessard; Janet Stavnezer; Lindsay S Shopland; Kevin D Mills
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

Review 6.  Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair.

Authors:  Allysia J Matthews; Simin Zheng; Lauren J DiMenna; Jayanta Chaudhuri
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

7.  AID-RNA polymerase II transcription-dependent deamination of IgV DNA.

Authors:  Phuong Pham; Sohail Malik; Chiho Mak; Peter C Calabrese; Robert G Roeder; Myron F Goodman
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

8.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

9.  Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy.

Authors:  Shyh-Jen Shih; Joseph Fass; Vincent Buffalo; Dawei Lin; Sheetal P Singh; Manuel O Diaz; Andrew T Vaughan
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998

Review 10.  AID targeting: old mysteries and new challenges.

Authors:  Vivek Chandra; Alexandra Bortnick; Cornelis Murre
Journal:  Trends Immunol       Date:  2015-08-04       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.